| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 31 |
| 1 | PACLITAXEL | 26 |
| 2 | PACLITAXEL (AIBUMIN-BOUND) | 26 |
| 3 | DOSTARLIMAB | 16 |
| 4 | PEMBROLIZUMAB | 16 |
| 5 | LENVATINIB | 10 |
| 6 | DURVALUMAB | 9 |
| 7 | LEVONORGESTREL | 8 |
| 8 | TRASTUZUMAB | 8 |
| 9 | OLAPARIB | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOSTARLIMAB | 16 | 0.0064 |
| 1 | PEGFILGRASTIM-CBQV | 1 | 0.0007 |
| 2 | DURVALUMAB | 9 | 0.0004 |
| 3 | APREPITANT | 3 | 0.0004 |
| 4 | SOTALOL HYDROCHLORIDE TABLES AF | 1 | 0.0004 |
| 5 | SOTALOL HYDROCHLORIDE TABLETS AF | 1 | 0.0004 |
| 6 | ADALIMUMAB-AFZB | 1 | 0.0004 |
| 7 | LENVATINIB | 10 | 0.0003 |
| 8 | ENASIDENIB MESYLATE | 1 | 0.0003 |
| 9 | OLAPARIB | 6 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 9 | 0.0004 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 32 | 0.0003 |
| 3 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 6 | 0.0003 |
| 4 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 5 | Microtubule Inhibitor [EPC] | 27 | 0.0002 |
| 6 | Standardized Insect Venom Allergenic Extract [EPC] | 1 | 0.0001 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 9 | 0.0001 |
| 8 | Platinum-based Drug [EPC] | 31 | 0.0001 |
| 9 | GLP-2 Analog [EPC] | 1 | 0.0001 |